Avian, Alice
Clemente, Nicolò
Mauro, Elisabetta
Isidoro, Erica
Di Napoli, Michela
Dudine, Sandra
Del Fabro, Anna
Morini, Stefano
Perin, Tiziana
Giudici, Fabiola
Cammisuli, Tamara
Foschi, Nicola
Mocenigo, Marco
Montrone, Michele
Modena, Chiara
Polenghi, Martina
Puzzi, Luca
Tomaic, Vjekoslav
Valenti, Giulio
Sola, Riccardo
Zanolla, Shivani
Vogrig, Enea
Riva, Elisabetta
Angeletti, Silvia
Ciccozzi, Massimo
Castriciano, Santina
Pachetti, Maria
Petti, Matteo
Centonze, Sandro
Gerin, Daniela
Banks, Lawrence
Marini, Bruna
Canzonieri, Vincenzo
Sopracordevole, Francesco
Zanconati, Fabrizio
Ippodrino, Rudy
Funding for this research was provided by:
Ulisse Biomed
Article History
Received: 25 February 2022
Accepted: 7 April 2022
First Online: 17 May 2022
Change Date: 26 January 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12967-023-03882-5
Declarations
:
: The local ethics committee approval was obtained for the present study (ASUGI Trieste n. 16008/2018; CRO Aviano n. 17149/2018). The study was conducted in accordance with the Helsinki Declaration [CitationRef removed, CitationRef removed] and revised to comply with GCP standards [CitationRef removed].
: Not applicable.
: AA and MaM conducted their PhD projects at the Ulisse BioMed S.p.A. company; EM, NF, MiM, LP, GV, RS, BM, RI, MPe, RS, GV were/are employees at the Ulisse BioMed S.p.A..; RI, BM AA, EM, MaM, MiM, and NF are inventors of the patents; RI, BM, EM, MaM and MPe are shareholders of Ulisse BioMed; SC is the Global Scientific Affairs Director at Copan Italia S.p.a. All the other authors declare that they have no conflict of interest.